44 2033180199

Metabolic illness treatment using polydatin's pharmacological effects

Audrey Darville, Paul Wheatley

Chronic conditions known as metabolic diseases (MDs) significantly reduce patients' quality of life while also placing a significant financial burden on them. A growing body of research indicates that Polydatin (PD), a significant resveratrol glucoside, is present in a wide variety of plants and has demonstrated promising results in treating metabolic disorders.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.
 
Publicación de revisión por pares para asociaciones, sociedades y universidades pulsus-health-tech
Top